Navigation Links
Study Suggests New Treatment Approach May be Needed for Management of Depression in Some People With Bipolar Disorder
Date:2/11/2009

tients who stopped taking the antidepressant due to lack of effectiveness or worsening depressive symptoms.

"We found that people who had minimal manic symptoms or a "mixed depression" presentation were at greatest risk for experiencing TEM," says Dr. Frye.

Experts have begun to acknowledge that the common understanding of bipolar illness, once thought to be a disorder with two distinct phases (a manic upswing and a depressive downswing), may be incomplete. A recent study of over 1,300 patients conducted by Joseph Goldberg, M.D., Mount Sinai School of Medicine, reported that two-thirds of the depressed bipolar patients had minimal or mild manic symptoms "mixed" together.

"We're learning that this illness does not occur in two neat, clear-cut phases, but rather a mix of the two," says Dr. Frye. "Our data would suggest that people with mixed depression may need to stay away from antidepressants and work with their health care providers to find alternative treatments, such as mood stabilizers, to help manage the depressive phase of their illness." Further research is encouraged to better understand the best treatment for these mixed presentations.

Other authors for this article include: Gerhard Helleman, Ph.D., David Geffen School of Medicine at UCLA, Los Angeles; Susan McElroy, M.D., University of Cincinnati College of Medicine; Lori Altshuler, M.D., David Geffen School of Medicine at UCLA, Los Angeles; David Black, Ph.D., Pediatric and Developmental Neuropsychiatry, National Institute of Mental Health (NIMH), National Institutes of Health (NIH), Bethesda, Md., and David Geffen School of Medicine at UCLA, Los Angeles; Paul Keck Jr., M.D., University of Cincinnati College of Medicine; Willem Nolen, M.D., Ph.D., University Medical Center Groningen, University of Groningen, the Netherlands; Ralph Kupka, M.D., Ph.D., Altrecht Institute for Mental He
'/>"/>

SOURCE Mayo Clinic
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... May 28, 2015 Another clinic ... of the future. In connection with extensive modernization measures, ... Majorca is equipping its clinic with state-of-the-art ... to install the innovative ClinicAll System, thereby achieving two ... infotainment services for patients, ClinicAll also offers significant advantages ...
(Date:5/28/2015)... , May 28, 2015 Kindred Biosciences, ... appointment of Jennifer Elliott as Vice ... Dr. Elliott joins KindredBio from Genentech, ... Counsel and Director of Patent Law.  She had ... year tenure with Genentech, and most recently oversaw ...
(Date:5/28/2015)... -- Janssen Pharmaceuticals, Inc. (Janssen) and its development partner, Bayer ... comprehensive clinical research program for their novel oral anticoagulant, ... evaluating the medicine for the prevention and treatment of ... of cancer types. In patients with ... a blood clot in the deep veins or the ...
Breaking Medicine Technology:Groundbreaking Step Towards a Cost-efficient Future 2KindredBio Announces Appointment of Jennifer Elliott as Vice President of Legal Affairs and Intellectual Property 2New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 2New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 3New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 4New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 5New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 6New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 7New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 8New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 9New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 10New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 11New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 12
(Date:5/28/2015)... RI (PRWEB) May 28, 2015 As the ... beach to keep cool. It’s important to make safety a ... is sharing some swimming tips. , According to the Centers ... in the United States, not including boating incidents. Additionally, the ... death for children ages 1 to 4. , Amica ...
(Date:5/28/2015)... Lauderdale, Florida (PRWEB) May 28, 2015 ... Havlicek, and wife Beth, both Genesis Foundation Board of ... Annual John Havlicek Celebrity Fishing Tournament June 4-7. For ... this 4-day event benefitting The Genesis Foundation for children ... the cause. , The 34th John Havlicek Celebrity ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 The CEO ... announced a just launched blog series which provides analysis ... Hosted on the “R. Bruce Dalglish” profile on Blogger.com, ... R. Bruce Dalglish’s corporate experience. , “Throughout my ... workplace cultures have upon the overall success of businesses,” ...
(Date:5/28/2015)... 2015 Nidra Herbal Sleep Supplement features a ... body. A non-addictive supplement, Nidra Herbal Sleep Supplement is more ... will leave users with a real sense of wellbeing the ... Ayurveda, which translates as the “Science or Knowledge of Life”, ... and is a holistic system of knowledge which combines contemplation, ...
(Date:5/28/2015)... 2015 Baptist Medical Center Jacksonville has ... from acute stroke or other neurological conditions. , The ... a few in the country and the first in ... such as brain aneurysms. , “Baptist Health is ... patients who are impacted by stroke,” said Nicole Thomas, ...
Breaking Medicine News(10 mins):Health News:Splash! Amica Shares 6 Swimming Safety Tips 2Health News:The Genesis Foundation Prepares for Their Final Annual John Havlicek Celebrity Fishing Tournament 2Health News:R. Bruce Dalglish, CEO of Alliance Hospice, Introduces New Blog Series On Positive Corporate Culture 2Health News:Ayurveda Herba Corp’s Revolutionary Herbal Sleep Supplement is Now Available from Amazon.com 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 3
... , HOUSTON , Feb. 8 ... technology are invited to visit the NASA Goes the Distance exhibit ... Expo at the Palmer Event Center. NASA,s exhibit will be open ... 10 a.m. to 6 p.m. Saturday . The exhibit will ...
... MONDAY, Feb. 8 (HealthDay News) -- Decreased handgrip strength in ... say. , In a new study, handgrip strength was measured ... group of 555 participants in the Netherlands. The researchers found ... a greater decline in strength over time, was associated with ...
... New York,s ... , ... February 8, 2010 -- As a proactive measure, New York City and the Environmental Protection ... with the support of personal injury attorneys. As reported by The New York Times ...
... , Feb. 8 Aton Pharma, Inc., a ... Richardson has joined the company as Vice President, Commercial ... Donald A. Fishbein assumes the same role for the ... Holdings LLC, Aton is focused on the development and commercialization ...
... , , , , , ... Feb. 8 /PRNewswire-Asia-FirstCall/ -- Renhuang,Pharmaceuticals, Inc. (Pink Sheet: ... botanical products,bio-pharmaceuticals and traditional Chinese medicines ("TCM"), announced today,that it ... fiscal year ended, October 31, 2009 on time. In ...
... ... NuEarth Corporation (Pinksheets: NUEC) (“NuEarth”), a manufacturer and ... that the company’s Laboratory and Research Division “TerraSolv SA” has ... contract representing an additional $1.3 Million laboratory service contract with ...
Cached Medicine News:Health News:NASA Joins Austin Marathon Expo, Inspires Students 2Health News:Handgrip Strength Helps Predict Death Risk in Elderly 2Health News:New York Examines Possible Contamination in Public City Schools 2Health News:Aton Pharma Announces Michael H. Richardson to Head Orphan Drug Division 2Health News:Renhuang Reports Record Fiscal 2009 Results; Resumes Compliance With SEC Filing Requirements 2Health News:Renhuang Reports Record Fiscal 2009 Results; Resumes Compliance With SEC Filing Requirements 3Health News:NuEarth Signs $1.3 Million Laboratory Contract 2Health News:NuEarth Signs $1.3 Million Laboratory Contract 3
... and custom shields and barriers for superior radiation ... or high level radiation shielding, we have a ... lead acrylic, lead glass, lead vinyl or a ... offer shielding from 1/32" thick to 2" and ...
Height-Adjustable Mobile X-ray Barrier lets you get close to your patient during special procedures like cardiac cath. 24"H x 36"W viewing panel shields the upper body of one or two people and swivel...
Ball-and-socket center mount can rotate 360, allowing them to be turned hoirzontally, vertically, or at any angle. Very versatile! Available with or without torso placement contour cutout and in thre...
Wrap-Around, Full Protection Apron with BACK SUPPORT...
Medicine Products: